Plain-English translation of NCT06390371 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes Mellitus research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new tool called Spotlight AQ—an artificial intelligence-powered survey that asks you personalized questions about your diabetes care before your clinic visits. The goal is to see whether using this tool helps you and your healthcare team work together more effectively, and whether it can help lower your blood sugar levels over time.
Right now, patients fill out standard pre-clinic surveys that don't always focus on what matters most to them individually. Researchers want to know if a smarter, personalized survey tool can help identify your biggest concerns and gaps in care, making your clinic visits more helpful and improving your overall diabetes management.
You likely qualify if…
You likely don't qualify if…
You would use the Spotlight AQ survey on your phone or computer before two regular diabetes clinic visits. The survey takes just a few minutes and asks personalized questions about your diabetes care. After using it, you'll fill out feedback surveys about your experience, and you may be invited to have a short conversation with a researcher about what you thought of the tool. The whole study takes place over the course of your normal clinic visits—no extra hospital visits needed.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States